Genética y Clínica de las Neoplasias Hematológicas y el Trasplante Hematopoyético

Gomez-Centurion, I; Oarbeascoa, G; Garcia, MC; Fresnena, MCL; Carreno, MJM; Vilaplana, VE; Gonzalez-Haba, E; Bailen, R; Dorado, N; Juarez, LM; Macias, GR; Lopez, PF; Encinas, C; Bastos-Oreiro, M; Anguita, J; Sanjurjo, M; Diez-Martin, JL; Kwon, M.

Implementation of a hospital-at-home (HAH) unit for hematological patients during the COVID-19 pandemic: safety and feasibility

INTERNATIONAL JOURNAL OF HEMATOLOGY. 2022; 115(1): 61-68 Nº de citas: 11 [doi:10.1007/s12185-021-03219-2]

Duque, P; Chasco-Ganuza, M; Ortuzar, A; Almaraz, C; Terradillos, E; Perez-Rus, G; Pascual, C.

Acquired FXIII Deficiency is Associated with High Morbidity

THROMBOSIS AND HAEMOSTASIS. 2022; 122(1): 48-56 Nº de citas: 9 [doi:10.1055/a-1481-2733]

Castro-Vazquez D; Lamana A; Arribas-Castaño P; Gutiérrez-Cañas I; Villanueva-Romero R; Pérez-García S; Martínez C; Juarranz Y; Fernández de Córdoba S; González-Álvaro I; Gomariz RP; Carrión M.

The Neuropeptide VIP Limits Human Osteoclastogenesis: Clinical Associations with Bone Metabolism Markers in Patients with Early Arthritis.

Biomedicines. 2021; 9(12): [doi:10.3390/biomedicines9121880]

Alvarez-Uria, A; Escribano, P; Parra-Blanco, V; Cano-Lira, JF; Stchigel, AM; Oarbeascoa, G; Munoz, P; Guinea, J.

First Report of an Invasive Infection by Cephalotrichum gorgonifer in a Neutropenic Patient with Hematological Malignancy under Chemotherapy

Journal of Fungi. 2021; 7(12): Nº de citas: 1 [doi:10.3390/jof7121089]

Abrisqueta, P; Loscertales, J; Terol, MJ; Payer, AR; Ortiz, M; Perez, I; Cuellar-Garcia, C; de la Mata, MF; Rodriguez, A; Lario, A; Delgado, J; Godoy, A; Perez, JMA; Berruezo, MJ; Oliveira, A; Hernandez-Rivas, JA; Malo, MDG; Medina, A; Martin, PG; Osorio, S; Baltasar, P; Fernandez-Zarzoso, M; Marco, F; Mancenido, MJV; Simonovich, AS; Rubio, ML; Jarque, I; Suarez, A; Alvarez, RF; Anchel, AL; Rios, E; Castillo, MDL; Persona, EP; Munoz, RG; Ramos, R; Yanez, L; Bello, JL; Loriente, C; Acha, D; Villanueva, M.

Real-World Characteristics and Outcome of Patients Treated With Single-Agent Ibrutinib for Chronic Lymphocytic Leukemia in Spain (IBRORS-LLC Study)

Clinical Lymphoma Myeloma & Leukemia. 2021; 21(12): 985-999 Nº de citas: 22 [doi:10.1016/j.clml.2021.07.022]

Gallego, S; Bernabeu, D; Garrido-Pontnou, M; Guillen, G; Hindi, N; Juan-Ribelles, A; Marquez, C; Mata, C; Orcajo, J; Ramirez, G; Ramos, M; Romagosa, C; Ruano, D; Rubio, P; Verges, R; Valverde, C; SEHOP Soc Espanola Hematologia Onc.

GEIS-SEHOP clinical practice guidelines for the treatment of rhabdomyosarcoma

CLINICAL & TRANSLATIONAL ONCOLOGY. 2021; 23(12): 2460-2473 Nº de citas: 9 [doi:10.1007/s12094-021-02654-1]

Steensma, DP; Wermke, M; Klimek, VM; Greenberg, PL; Font, P; Komrokji, RS; Yang, J; Brunner, AM; Carraway, HE; Ades, L; Al-Kali, A; Alonso-Dominguez, JM; Alfonso-Pierola, A; Coombs, CC; Deeg, HJ; Flinn, I; Foran, JM; Garcia-Manero, G; Maris, MB; McMasters, M; Micol, JB; De Oteyza, JP; Thol, F; Wang, ES; Watts, JM; Taylor, J; Stone, R; Gourineni, V; Marino, AJ; Yao, HL; Destenaves, B; Yuan, XB; Yu, K; Dar, S; Ohanjanian, L; Kuida, K; Xiao, JJ; Scholz, C; Gualberto, A; Platzbecker, U.

Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms

LEUKEMIA. 2021; 35(12): 3542-3550 Nº de citas: 128 [doi:10.1038/s41375-021-01328-9]

Rubio-San-Simon, A; Alvaro, RH; Ribelles, AJ; Heredia, AC; Guerra-Garcia, P; Verdu-Amoros, J; Andres, M; Canete, A; Rives, S; Perez-Martinez, A; Mora, J; Patino-Garcia, A; Lassaleta, A; Llort, A; Ramirez, M; Mata, C; Gallego, S; Martin-Broto, J; Cruz, O; La Madrid, AM; Solano, P; Romera, IM; Fernandez-Teijeiro, A; Bautista, F; Moreno, L.

The paediatric cancer clinical research landscape in Spain: a 13-year multicentre experience of the new agents group of the Spanish Society of Paediatric Haematology and Oncology (SEHOP)

CLINICAL & TRANSLATIONAL ONCOLOGY. 2021; 23(12): 2489-2496 Nº de citas: 4 [doi:10.1007/s12094-021-02649-y]

Bastos-Oreiro, M; Suarez-Gonzalez, J; Andres-Zayas, C; Carrion, NC; Moreno, S; Carbonell, D; Chicano, M; Muniz, P; Sanz, L; Diaz-Crespo, FJ; Menarguez, J; Diez-Martin, JL; Buno, I; Martinez-Laperche, C.

Incorporation of next-generation sequencing in clinical practice using solid and liquid biopsy for patients with non-Hodgkin's lymphoma

Scientific Reports. 2021; 11(1): 22815-22815 Nº de citas: 8 [doi:10.1038/s41598-021-02362-4]

Rios-Tamayo, R; Puig, N; Algarin, M; Silva, JLGD; Barbosa, N; Encinas, C; Hernandez, JA; Alonso, R; Campos, ML; Rodriguez, T; Leivas, A; Olivares, MJ; Sanchez, MJ; Paiva, B; Lahuerta, JJ; Martinez-Lopez, J.

The Current Role of the Heavy/Light Chain Assay in the Diagnosis, Prognosis and Monitoring of Multiple Myeloma: An Evidence-Based Approach

Diagnostics. 2021; 11(11): Nº de citas: 6 [doi:10.3390/diagnostics11112020]

Infante, MS; Fernandez-Cruz, A; Nunez, L; Carpio, C; Jimenez-Ubieto, A; Lopez-Jimenez, J; Vasquez, L; Del Campo, R; Romero, S; Alonso, C; Morillo, D; Prat, M; Plana, JL; Villafuerte, P; Bastidas, G; Bocanegra, A; Serna, A; De Nicolas, R; Marquet, J; Mas-Ochoa, C; Cordoba, R; Garcia-Suarez, J; Comai, A; Martin, X; Bastos-Oreiro, M; Seri, C; Navarro-Matilla, B; Lopez-Guillermo, A; Martinez-Lopez, J; Hernandez-Rivas, JA; Ruiz-Camps, I; Grande, C; GELTAMO.

Severe infections in patients with lymphoproliferative diseases treated with new targeted drugs: A multicentric real-world study

Cancer Medicine. 2021; 10(21): 7629-7640 Nº de citas: 12 [doi:10.1002/cam4.4293]

Bastos-Oreiro, M; Ortiz, J; Pradillo, V; Salas, E; Marinez-Laperche, C; Munoz, A; Buno, I; Diez-Martin, JL; Soria, JM; Izquierdo, CP.

Incorporating genetic and clinical data into the prediction of thromboembolism risk in patients with lymphoma

Cancer Medicine. 2021; 10(21): 7585-7592 Nº de citas: 8 [doi:10.1002/cam4.4280]

GIL, S.; CARBONELL, D.; LOPEZ, L.; MIGUENS, I.; ALONSO, R.; BUÑO, I.; Muñoz, P.; Ochando Cano, Jordi; PION, M.; CORREA, R..

Induction of High Levels of Specific Humoral and Cellular Responses to SARS-CoV-2 After the Administration of Covid-19 mRNA Vaccines Requires Several Days

Frontiers in Immunology. 2021; 12: 726960-726960 Nº de citas: 18 [doi:10.3389/fimmu.2021.726960]

Martin-Rojas, RM; Chasco-Ganuza, M; Casanova-Prieto, S; Delgado-Pinos, VE; Perez-Rus, G; Duque-Gonzalez, P; Sancho, M; Diez-Martin, JL; Pascual-Izquierdo, C.

A mild deficiency of ADAMTS13 is associated with severity in COVID-19: comparison of the coagulation profile in critically and noncritically ill patients

BLOOD COAGULATION & FIBRINOLYSIS. 2021; 32(7): 458-467 Nº de citas: 10 [doi:10.1097/MBC.0000000000001068]

Martinez-Solano, J; Ortiz-Bautista, C; Zatarain-Nicolas, E; Sousa-Casasnovas, I; Pedraz-Prieto, A; Barrio-Gutierrez, JM; Pascual-Izquierdo, C; Fernandez-Aviles, F.

Management of Intracranial Hemorrhage During Pulsatile Long-Term Biventricular Support: When Necessity Is the Mother of Invention

ASAIO JOURNAL. 2021; 67(10): 172-175 [doi:10.1097/MAT.0000000000001353]

Ribera, JM; Morgades, M; Coll, R; Barba, P; Lopez-Lorenzo, JL; Montesinos, P; Foncillas, MA; Cabrero, M; Gomez-Centurion, I; Morales, MD; Varela, MR; Herrera, P; Garcia-Cadenas, I; Calbacho, M; Torrent, A; Maluquer, C; Calabuig, M; Garcia-Guinon, A; Bautista, G; Llorente, L; Gil, C; Artola, MT; Gonzalez-Campos, J; Fernandez-Moreno, A; Barez, A; Gimenez-Perez, T; Bergua, J; Sanchez-Sanchez, MJ; Mateos, MC; Pinana, JL.

Frequency, Clinical Characteristics and Outcome of Adults With Acute Lymphoblastic Leukemia and COVID 19 Infection in the First vs. Second Pandemic Wave in Spain

Clinical Lymphoma Myeloma & Leukemia. 2021; 21(10): 801-809 Nº de citas: 16 [doi:10.1016/j.clml.2021.06.024]

Genesca, E; Morgades, M; Gonzalez-Gil, C; Fuster-Tormo, F; Haferlach, C; Meggendorfer, M; Montesinos, P; Barba, P; Gil, C; Coll, R; Moreno, MJ; Martinez-Carballeira, D; Garcia-Cadenas, I; Vives, S; Ribera, J; Gonzalez-Campos, J; Diaz-Beya, M; Mercadal, S; Artola, MT; Cladera, A; Tormo, M; Bermudez, A; Vall-llovera, F; Martinez-Sanchez, P; Amigo, ML; Monsalvo, S; Novo, A; Cervera, M; Garcia-Guinon, A; Ciudad, J; Cervera, J; Hernandez-Rivas, JM; Granada, I; Haferlach, T; Orfao, A; Sole, F; Ribera, JM.

Adverse prognostic impact of complex karyotype (>= 3 cytogenetic alterations) in adult T-cell acute lymphoblastic leukemia (T-ALL)

LEUKEMIA RESEARCH. 2021; 109: 106612-106612 Nº de citas: 12 [doi:10.1016/j.leukres.2021.106612]

Ribera, JM; Morgades, M; Genesca, E; Chapchap, EC; Montesinos, P; Acuna-Cruz, E; Gil, C; Garcia-Cadenas, I; Barba, P; Gonzalez-Campos, J; de Llano, MPQ; Torrent, A; Ribera, J; Granada, I; Bernal, T; Diaz-Beya, M; Amigo, ML; Coll, R; Tormo, M; Vall-llovera, F; Gomez-Centurion, I; Sanchez-Sanchez, MJ; Soria, B; Cladera, A; Artola, MT; Garcia-Guinon, A; Gimenez-Conca, A; Amador, ML; Martinez-Sanchez, P; Algarra, JL; Vidal, MJ; Alonso, N; Maluquer, C; Llorente, L; Garcia-Boyero, R; Ciudad, J; Feliu, E; Orfao, A; PETHEMA Grp.

Outcomes and prognostic factors of adults with refractory or relapsed T-cell acute lymphoblastic leukemia included in measurable residual disease-oriented trials

HEMATOLOGICAL ONCOLOGY. 2021; 39(4): 529-538 Nº de citas: 8 [doi:10.1002/hon.2910]